by mroseboro | Jun 23, 2023 | Adyogan Ozcan, Engineering, Faculty News, HEALTH + MEDICINE, Member News, News, Research |
FEATURED NEWS California NanoSystems Institute > Faculty News > Adyogan Ozcan New rapid viral plaque detection system, aided by deep learning and holographic imaging, can help accelerate vaccine and drug development CNSI RESEARCH BRIEF Figure: Viral plaque...
by mroseboro | Dec 7, 2022 | Bioengineering, Engineering, Faculty News, HEALTH + MEDICINE, News, Noble Family Innovation Fund, Research |
FEATURED NEWS California NanoSystems Institute > Faculty News Wearable sensor could guide precision drug dosing In test with rats, UCLA-developed patch predicted total dosage that would be delivered to animals’ bloodstream By Wayne Lewis The sensor uses...
by mroseboro | Mar 29, 2022 | Entrepreneurship, Faculty News, HEALTH + MEDICINE, News, Research, Women in STEM |
FEATURED NEWS California NanoSystems Institute > Articles by: mroseboro Q&A with Dr. Gay Crooks: “5 Questions With” Dr. Crooks is the Rebecca Smith Professor in the Department of Pathology & Laboratory Medicine and Professor of Pediatrics in the...
by mroseboro | Mar 24, 2022 | Faculty News, HEALTH + MEDICINE, News, Noble Family Innovation Fund, Research, Women in STEM |
FEATURED NEWS California NanoSystems Institute > News To fight diseases of aging, scientist makes aging itself the target UCLA’s Ming Guo takes a unique approach to addressing neurodegenerative disease By Wayne Lewis Guo sometimes invites her patients to speak at...
by mroseboro | Dec 10, 2021 | Faculty News, HEALTH + MEDICINE, Member News, News, Research, Uncategorized |
FEATURED NEWS California NanoSystems Institute > 2021 > December A longer-lasting COVID vaccine? UCLA study points the way UCLA RESEARCH BRIEF By Tiare Dunlap Silicon wafers coated with the gradient ENZ materials viewed through a thermal imaging camera (Image...
by mroseboro | Nov 29, 2021 | Faculty News, HEALTH + MEDICINE, News, Research |
FEATURED NEWS California NanoSystems Institute > Faculty News Anti-cancer drug identified by UCLA researchers shows promise treating high-risk COVID-19 patients Berzosertib is one of several repurposed drugs scientists are studying to treat the virus. by UCLA...
Recent Comments